Title: Chief Medical Officer
Company: NextCure, Inc.
Location: Bethesda, Maryland, United States
Han Myint, MD, chief medical officer at NextCure, Inc., has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in hematology and oncology.
With over 30 years of experience to his credit, Dr. Myint has found success as the chief medical officer at NextCure, Inc. since 2021. Bearing a wealth of in-depth scientific knowledge surrounding solid tumors, hemaotlogical malignancies and stem cell transportation, he began his career as a professor of hematology at King’s College London. Subsequently, he worked as a consultant hematologist and faculty member at the University of Southampton. He served as a member of IFIG from 1997 to 2001. He immigrated to the United States in 2001.
Dr. Myint continued his career at Rush University Medical Center as a visiting professor and director of the Hematology/Oncology Fellowship Program from 2001 to 2005. He transitioned to the role of founder and director of the Hematological Malignancies and Stem Cell Transplant Program at the University of Colorado Denver from 2005 to 2012. He thrived as senior vice president of global medical affairs and the myeloid diseases lead at Cell Therapeutics, Inc. from 2012 to 2013. He established himself as vice president of global medical affairs – MDS/AML at Celgene Corporation from 2013 to 2019. He garnered a stellar reputation as chief medical officer at NexImmune, Inc. from 2020 to 2021.
Before embarking on his professional path, Dr. Myint pursued an education at the Institute of Medicine, now the University of Medicine, in Yangon, Myanmar, where he earned a Bachelor of Medicine and Bachelor of Surgery. He pursued postgraduate training in internal medicine and hematology in the United Kingdom. In light of his impressive undertakings, he has accrued several accolades throughout his career, including designation as a fellow of the American College of Physicians, the Royal College of Physicians of Edinburgh, the Royal College of Physicians and Surgeons of Glasgow and the Royal College of Pathologists of United Kingdom. He was recognized among the Best Doctors in America between 2009 and 2012 and was frequently awarded bonuses by Celgene Corporation in acknowledgment of his outstanding contributions. A board member for the Denver Chapter of the Leukemia and Lymphoma Society as well as the Bonfil Blood Center, Dr. Myint was inducted into Who’s Who in Montclair, named Pioneer of the Year, and contributed to efforts that were awarded Outstanding Service of the Year.
Dr. Myint was inspired to pursue a career as a medical doctor when he was 11 years old and encountered A.J. Cronin’s autobiography, “Adventures in Two Worlds,” which chronicled the challenges the author faced while navigating his dual roles as a doctor and a novelist. Despite financial constraints that deterred his father from sending him to England, he tenaciously fulfilled his dream of studying medicine there. To honor his late mother, he opted to specialize in hematology and oncology.
Dr. Myint takes pride in his achievements in advancing therapeutic options and affording individuals the opportunity to live extended and healthier lives. Having accomplished this significant milestone, he envisions his next potential achievement to be the development of a cure for at least one disease, further exemplifying his relentless commitment to creating medical breakthroughs. In the immediate future, he is committed to continuing his work in advancing groundbreaking medical options.
For more information, please visit:
Contact Dr. Myint:
